Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Gossamer Bio, Inc. (GOSS) had Revenue of $9.89M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$9.89M
Net Income	$-36.64M
Cost of Goods Sold	--
Gross Profit	$9.89M
Operating Expenses	$46.70M
Operating Income	$-36.81M
Non-Operating Income/Expense	$0.17M
Pre-Tax Income	$-36.64M
Normalized Pre-Tax Income	$-36.64M
Income after Taxes	$-36.64M
Income from Continuous Operations	$-36.64M
Consolidated Net Income/Loss	$-36.64M
Normalized Income after Taxes	$-36.64M
EBIT	$-36.81M
EBITDA	$-38.89M
Weighted-Average Shares Outstanding (Basic)	226.82M
Weighted-Average Shares Outstanding (Diluted)	226.82M
Earnings per Share (EPS) (Basic)	$-0.16
Earnings per Share (EPS) (Diluted)	$-0.16
Balance Sheet Financials
Current Assets	$275.48M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$5.11M
Total Assets	$280.59M
Current Liabilities	$48.22M
Long-Term Debt	$197.76M
Long-Term Liabilities	$238.62M
Total Liabilities	$286.84M
Common Equity	$-6.25M
Tangible Shareholders Equity	$-6.25M
Shareholders Equity	$-6.25M
Common Shares Outstanding	227.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-39.72M
Cash Flow from Investing Activities	$22.06M
Cash Flow from Financial Activities	$0.50M
Beginning Cash	$46.07M
End Cash	$29.02M
Increase/Decrease in Cash	$-17.05M
Stock-Based Compensation	$2.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.03
Debt to Equity Ratio	-31.64
Gross Margin	100.00%
Operating Margin	-372.23%
EBIT Margin	-372.23%
EBITDA Margin	--
Pre-Tax Profit Margin	-370.49%
Profit Margin	-370.49%
Free Cash Flow	$-39.75M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.04
Inventory Turnover	--
Receiveable Turnover	1.50
Days Sales in Receivables	59.91
Return on Equity	586.19%
Return on Tangible Equity	586.21%
Return on Assets	-13.06%
Return on Investments	-19.13%
Book Value Per Share	$-0.03
Free Cash Flow per Share	$-0.18
Operating Cash Flow per Share	$-0.18

Data from Zacks Investment Research, Inc.